Lineage, Inc. (LINE)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds
Lineage remains a buy, supported by strong fundamentals and a leading position in temperature-controlled warehouse REITs despite near-term macro headwinds. LINE delivered robust 2025 AFFO growth of 22.7% ($865M), but expects a ~14.7% per-share AFFO decline in 2026 amid weak occupancy and macro uncertainty. Dividend yield stands at 5.15% with a sustainable payout ratio, and management targets $110M run-rate cost savings over 3-5 years.
Lineage, Inc. (LINE) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Lineage, Inc. (LINE) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Lineage, Inc. (LINE) Beats Q4 FFO Estimates
Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to FFO of $0.83 per share a year ago.
Lineage Vs. Americold: Why Tech Leadership Makes LINE The Superior REIT
Lineage (LINE) stands out as the cold storage industry leader, leveraging proprietary technology and geographic diversification to drive structural cost advantages over peers. LINE's LinOS platform is a significant competitive advantage, expected to boost margins and productivity, though rollout delays present near-term execution risk. Industry oversupply is being absorbed, with demand now outpacing new supply; LINE's 6% dividend yield is well covered and supported by a conservative payout ratio.
Lineage: Cold-Storage REIT Getting Too Hot To Ignore
Lineage is reiterated as a buy, trading at a significant discount to NAV and intrinsic value estimates, with strong recovery potential. LINE offers a ~6.1% dividend yield at a sustainable ~64% payout ratio, with plenty of room for increases or buybacks. Despite macro headwinds and lowered guidance, LINE continues to expand, leveraging its scale for future accretive growth and even industry consolidation.
Lineage, Inc. (LINE) Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform Prepared Remarks Transcript
Lineage, Inc. (LINE) Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform Prepared Remarks Transcript
Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy
Lineage Cell Therapeutics' OpRegen is partnered with Genentech/Roche. In my view, this is their main value driver in GA dry AMD. Looking ahead, their GAlette Phase 2a trial is enrolling, which could further validate the rest of their portfolio's potential. LCTX's pipeline also has OPC1 for spinal cord injury. Its preclinical R&D includes ANP1, PNC1, RND1, and ILT1.
Lineage, Inc. (LINE) Q3 2025 Earnings Call Transcript
Lineage, Inc. ( LINE ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Ki Bin Kim W. Lehmkuhl - CEO, President & Director Robert Crisci - Chief Financial Officer Conference Call Participants Caitlin Burrows - Goldman Sachs Group, Inc., Research Division Michael Goldsmith - UBS Investment Bank, Research Division Steve Sakwa - Evercore ISI Institutional Equities, Research Division Craig Mailman - Citigroup Inc., Research Division Ronald Kamdem - Morgan Stanley, Research Division Michael Carroll - RBC Capital Markets, Research Division Alexander Goldfarb - Piper Sandler & Co., Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Greg McGinniss - Scotiabank Global Banking and Markets, Research Division Daniel Guglielmo - Capital One Securities, Inc., Research Division Vikram Malhotra - Mizuho Securities USA LLC, Research Division Blaine Heck - Wells Fargo Securities, LLC, Research Division Michael Lewis Samir Khanal - BofA Securities, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Todd Thomas - KeyBanc Capital Markets Inc., Research Division Nicholas Thillman - Robert W.
Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Lineage, Inc. (LINE) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ethic Inc. Acquires New Holdings in Lineage, Inc. $LINE
Ethic Inc. bought a new position in shares of Lineage, Inc. (NASDAQ: LINE) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 9,151 shares of the company's stock, valued at approximately $403,000. Several other institutional investors and hedge
Lineage: Leading Cold-Storage REIT Trading At Fire-Sale Prices
Lineage, the largest temperature-controlled warehouse REIT, is trading near all-time lows since 2024's IPO due to industry headwinds and recent guidance cuts. LINE maintains a solid 5.3% dividend yield with a sustainable payout ratio that could soon increase, and continues to invest in growth through partnerships and acquisitions. The stock trades at a significant discount to NAV, offering potential upside if occupancy rates improve and macroeconomic conditions become more favorable.
Lineage: A Deeply Discounted Cold Storage Giant Positioned To Consolidate The Industry
Lineage (LINE), the world's largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry consolidation, benefiting from global scale, high margins, and a strong competitive moat. Despite challenges like oversupply and cost inflation, LINE's valuation near book value and a 5.6% dividend yield create an attractive risk/reward setup.
